Gene expression signatures as a therapeutic target for severe H7N9 influenza - what do we know so far?

scientific article published on 20 January 2015

Gene expression signatures as a therapeutic target for severe H7N9 influenza - what do we know so far? is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.1517/14728222.2015.1006198
P698PubMed publication ID25600759

P50authorMichael KatzeQ21062265
Juliet MorrisonQ43081450
P2860cites work1918 Influenza: the mother of all pandemicsQ22305649
The Connectivity Map: a new tool for biomedical researchQ28530408
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistanceQ30222909
Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genomeQ30223081
Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment optionsQ30358704
H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in miceQ30364306
Influenza virus A/Anhui/1/2013 (H7N9) replicates efficiently in the upper and lower respiratory tracts of cynomolgus macaques.Q30365646
Pandemic potential of avian influenza A (H7N9) viruses.Q30367254
Clinical findings in 111 cases of influenza A (H7N9) virus infectionQ33407904
Glycan receptor binding of the influenza A virus H7N9 hemagglutininQ37102936
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infectionQ37495275
Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts.Q37643750
Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.Q37800572
Adaptation of novel H7N9 influenza A virus to human receptorsQ41816698
Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in ChinaQ42273286
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)447-450
P577publication date2015-01-20
P1433published inExpert Opinion on Therapeutic TargetsQ5421214
P1476titleGene expression signatures as a therapeutic target for severe H7N9 influenza - what do we know so far?
P478volume19

Reverse relations

cites work (P2860)
Q28551988MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication
Q91913130Systems biology approach: Panacea for unravelling host-virus interactions and dynamics of vaccine induced immune response
Q37739368Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment

Search more.